Cited by 6,471Cancer Genomics and DiagnosticsCancer Cells and MetastasisEvolution and Genetic Dynamics

The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.

The Clonal Evolution of Tumor Cell Populations: Acquired genetic lability permits stepwise selection of variant sublines and underlies tumor progression.

Nowell, Peter C.·1976·Science

Open this paper in CoChat — free account

Abstract

It is proposed that most neoplasms arise from a single cell of origin, and tumor progression results from acquired genetic variability within the original clone allowing sequential selection of more aggressive sublines. Tumor cell populations are apparently more genetically unstable than normal cells, perhaps from activation of specific gene loci in the neoplasm, continued presence of carcinogen, or even nutritional deficiencies within the tumor. The acquired genetic insta0ility and associated selection process, most readily recognized cytogenetically, results in advanced human malignancies being highly individual karyotypically and biologically. Hence, each patient's cancer may require individual specific therapy, and even this may be thwarted by emergence of a genetically variant subline resistant to the treatment. More research should be directed toward understanding and controlling the evolutionary process in tumors before it reaches the late stage usually seen in clinical cancer.

Integrity signals

Registry

Crossref · 10.1126/science.959840

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Mutation selection and the natural history of cancer
Cairns, J. (1975) · Nature · doi:10.1038/255197a0 · Cited by 1,592
Normal genetically mosaic mice produced from malignant teratocarcinoma cells.
Mintz, B., & Illmensee, K. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3585 · Cited by 1,179
Handbuch der allgemeinen pathologie
(1973) · Experimental Gerontology · doi:10.1016/0531-5565(73)90021-1 · Cited by 794
Glucose-6-Phosphate Dehydrogenase Mosaicism: Utilization as a Cell Marker in the Study of Leiomyomas
Linder, D., & Gartler, S. M. (1965) · Science · doi:10.1126/science.150.3692.67 · Cited by 398
Differentiation of malignant to benign cells
Kauffman, S. A. (1971) · Journal of Theoretical Biology · doi:10.1016/0022-5193(71)90020-8 · Cited by 309
Suppression of malignancy in human cells
Stanbridge, E. J. (1976) · Nature · doi:10.1038/260017a0 · Cited by 307
Methodology in mammalian genetics
Burdette, W. J. (1963) · Holden-Day eBooks · doi:10.5962/bhl.title.6428 · Cited by 302
Chromosomes and cancer
LEVAN, A., Levan, G., & Mitelman, F. (2009) · Hereditas · doi:10.1111/j.1601-5223.1977.tb01208.x · Cited by 263
The analysis of malignancy by cell fusion: I. hybrids between tumour cells and l cell derivatives
Klein, G., Bregula, U., Wiener, F., & Harris, H. (1971) · Journal of Cell Science · doi:10.1242/jcs.8.3.659 · Cited by 248
Neoplasia: a disease of cell differentiation.
Markert, C. L. (1968) · PubMed · Cited by 244

Flagged first, then by citations

Show all 52 references

1 of the 52 references couldn’t be matched to a known paper.

Research works printed but not linked: 24

ALSAADI, A, SEQUENTIAL CYTOGENETIC CHANGES IN EVOLUTION OFTRANSPLANTED THYROID TUMORS IN METASTATIC CARCINOMA IN FICHER RAT, CANCER RESEARCH 27: 1831 (1967).
BOYSE, E.A., CURRENT RES ONCOLOGY: 57 (1972).
DIPAOLO, J.A., KARYOLOGICAL INSTABILITY OF NEOPLASTIC SOMATIC-CELLS, IN VITRO-JOURNAL OF THE TISSUE CULTURE ASSOCIATION 11: 89 (1975).
FOLKMAN, J, S FUNDAMENTAL ASPECT: 331 (1975).
FURTH, J, NATIONAL CANCER INSTITUTE MONOGRAPHS 2: 148 (1960).
GERMAN, J, GENES WHICH INCREASE CHROMOSOMAL INSTABILITY IN SOMATIC CELLS AND PREDISPOSE TO CANCER, PROGRESS IN MEDICAL GENETICS 8: 61 (1972).
GOLUB, S.H., CANCER COMPREHENSIVE 4: 259 (1975).
GROUCHY, J.D., CHROMOSOMES CANCER: 287 (1974).
HANDEN, D.G., CHROMOSOMES CANCER: 151 (1974).
KLEIN, G, METHODOLOGY MAMMALIA: 407 (1963).
KNUDSON, A.G., HEREDITY AND CANCER IN MAN, PROGRESS IN MEDICAL GENETICS 9: 113 (1973).
MAKINO, S, ANN N Y ACAD SCI 64: 818 (1956).
Miller, E. C., The Molecular Biology of Cancer: 377 (1974).
NOWELL, P.C., CANCER COMPREHENSIVE 1: 3 (1975).
NOWELL, P.C., CHROMOSOMES CANCER J: 267 (1974).
ODELL, W, TXB ENDOCRINOLOGY: 1105 (1974).
Oksala, T., Chromosomes and Cancer: 239 (1974).
Pedersen, B., Proceedings of the Fourth International Congress on Human Genetics: 166 (1972).
Pitot, H. C., Molecular Biology of Cancer: 523 (1974).
Robbins, J. C., Cancer: A Comprehensive Treatise 4: 3 (1975).
RUBIN, H, SCIENCE 191: 241 (1976). · DOI
STICH, H.F., CANADIAN CANCER CONFERENCE 5: 99 (1963).
WOLMAN, S.R., CANCER COMPREHENSIVE 3: 155 (1975).
Yosida, T. H., Handbuch der Allgemeinen Pathologic: 677 (1975).

Sorted by citations

Items 701–800 of 1,016

Breast cancer stem cells: implications for therapy of breast cancer
Morrison, B. J., Schmidt, C., Lakhani, S. R., Reynolds, B. A., & López, J. A. (2008) · Breast Cancer Research · doi:10.1186/bcr2111 · Cited by 140
Immunohistochemical analysis of Bcl-2, Bcl-X, Mcl-1, and Bax in tumors of central and peripheral nervous system origin.
Krajewski, S., Krajewska, M., Ehrmann, J., Sikorska, M., Lach, B., Chatten, J., & Reed, J. C. (1997) · Europe PMC (PubMed Central) · Cited by 139
Endogenous and exogenous modulation of gap junctional intercellular communication: Toxicological and pharmacological implications
Trosko, J. E., Madhukar, B. V., & Chang, C. C. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90606-4 · Cited by 139
Phenotypic drift of metastatic and cell‐surface properties of mammary adenocarcinoma cell clones during growth in vitro
Neri, A., & Nicolson, G. L. (1981) · International Journal of Cancer · doi:10.1002/ijc.2910280612 · Cited by 139
Single-cell sequencing analysis characterizes common and cell-lineage-specific mutations in a muscle-invasive bladder cancer
Li, Y., Xu, X., Song, L., Hou, Y., Li, Z., Tsang, S. X., Li, F., McGee, K., Wu, K., Wu, H., et al. (2012) · GigaScience · doi:10.1186/2047-217x-1-12 · Cited by 136
Detection of early seeding of Richter transformation in chronic lymphocytic leukemia
Nadeu, F., Royo, R., Massoni-Badosa, R., Playà-Albinyana, H., García-Torre, B., Duran‐Ferrer, M., Dawson, K. J., Kulis, M., Díaz‐Navarro, A., Villamor, N., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01927-8 · Cited by 140
Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets
Su, G.-H., Xiao, Y., You, C., Zheng, R., Zhao, S., Sun, S., Zhou, J.-Y., Lin, L., Wang, H., Shao, Z., et al. (2023) · Science Advances · doi:10.1126/sciadv.adf0837 · Cited by 140
Evolution of tumor cell heterogeneity during progressive growth of individual lung metastases.
Poste, G. H., Tzeng, J., Doll, J., GREIG, R. G., Rieman, D. J., & Zeidman, I. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.21.6574 · Cited by 138
Metastasis Suppressor Genes
Hurst, D. R., & Welch, D. R. (2011) · International review of cytology · doi:10.1016/b978-0-12-385859-7.00003-3 · Cited by 140
Chromosome instability, chromosome transcriptome, and clonal evolution of tumor cell populations
Gao, C., Furge, K., Koeman, J. M., Dykema, K. J., Su, Y., Cutler, M. L., Werts, A. D., Haak, P., & Woude, G. F. V. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700631104 · Cited by 137
The multiple facets of drug resistance: one history, different approaches
Niero, E. L. D. O., Rocha-Sales, B., Lauand, C., Cortez, B. A., de Souza, M. M., Teixeira, P. R., Urabayashi, M. S., Martens, A. A., Neves, J. H., & Machado‐Santelli, G. M. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-33-37 · Cited by 138
EXPANDS: expanding ploidy and allele frequency on nested subpopulations
Andor, N., Harness, J. V., Müller, S., Mewes, H., & Petritsch, C. K. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt622 · Cited by 138
Important Role of FTO in the Survival of Rare Panresistant Triple-Negative Inflammatory Breast Cancer Cells Facing a Severe Metabolic Challenge
Singh, B., Kinne, H. E., Milligan, R. D., Washburn, L. J., Olsen, M. J., & Lucci, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159072 · Cited by 138
Carcinogenesis explained within the context of a theory of organisms
Sonnenschein, C., & Soto, A. M. (2016) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2016.07.004 · Cited by 137
Gene mutations in saliva as molecular markers for head and neck squamous cell carcinomas
Boyle, J. O., Mao, L., Brennan, J. A., Koch, W. M., Eisele, D. W., Saunders, J. R., & Sidransky, D. (1994) · The American Journal of Surgery · doi:10.1016/s0002-9610(05)80092-3 · Cited by 137
Metastatic variants are generated spontaneously at a high rate in mouse KHT tumor.
Harris, J. F., Chambers, A. F., Hill, R. P., & Ling, V. W. T. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.18.5547 · Cited by 137
Natural history of intraepithelial neoplasia in humans with implications for cancer chemoprevention strategy
Boone, C. W., Kelloff, G. J., & Steele, V. E. (1992) · American Journal of Otolaryngology · doi:10.1016/0196-0709(92)90036-s · Cited by 137
Origins of G1 arrest in senescent human fibroblasts
Stein, G. H., & Dulić, V. (1995) · BioEssays · doi:10.1002/bies.950170610 · Cited by 135
Somatic mosaicism: on the road to cancer
Fernández, L. C., Torres, M., & Real, F. X. (2015) · Nature reviews. Cancer · doi:10.1038/nrc.2015.1 · Cited by 137
Induction of a Timed Metabolic Collapse to Overcome Cancer Chemoresistance
van Gastel, N., Spinelli, J. B., Sharda, A., Schajnovitz, A., Baryawno, N., Rhee, C., Oki, T., Grace, E., Soled, H. J., Milosevic, J., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.07.009 · Cited by 148
Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity
Gimple, R. C., Yang, K., Halbert, M. E., Agnihotri, S., & Rich, J. N. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00486-x · Cited by 148
The molecular biology of esophageal adenocarcinoma
Koppert, L. B., Wijnhoven, B. P. L., van Dekken, H., Tilanus, H. W., & Dinjens, W. N. M. (2005) · Journal of Surgical Oncology · doi:10.1002/jso.20359 · Cited by 136
Cell culture of human colon adenomas and carcinomas.
Willson, J. K. V., Bittner, G., Oberley, T. D., Meisner, L. F., & Weese, J. L. (1987) · PubMed · Cited by 136
Different mutator phenotypes in Mlh1 - versus Pms2 -deficient mice
Yao, X., Buermeyer, A. B., Narayanan, L., Tran, D., Baker, S. M., Prolla, T. A., Glazer, P. M., Liskay, R. M., & Arnheim, N. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6850 · Cited by 138
Abrogation of radioresistance in glioblastoma stem‐like cells by inhibition of ATM kinase
Carruthers, R., Ahmed, S. U., Strathdee, K. E., Gomez-Roman, N., Amoah-Buahin, E., Watts, C., & Chalmers, A. J. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.08.003 · Cited by 139
Cooperation and Conflict in the Evolution of Individuality. I. Multilevel Selection of the Organism
Michod, R. E. (1997) · The American Naturalist · doi:10.1086/286012 · Cited by 135
Emergence of spatial structure in the tumor microenvironment due to the Warburg effect
Carmona‐Fontaine, C., Bucci, V., Akkari, L., Déforet, M., Joyce, J. A., & Xavier, J. B. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311939110 · Cited by 140
Aneuploidy, the Primary Cause of the Multilateral Genomic Instability of Neoplastic and Preneoplastic Cells
DUESBERG, P. H., Fabarius, A. C., & Hehlmann, R. (2004) · IUBMB Life · doi:10.1080/15216540410001667902 · Cited by 136
Understanding and overcoming tumor heterogeneity in metastatic breast cancer treatment
Pasha, N., & Turner, N. C. (2021) · Nature Cancer · doi:10.1038/s43018-021-00229-1 · Cited by 135
Wnt/β-Catenin Signaling as a Driver of Hepatocellular Carcinoma Progression: An Emphasis on Molecular Pathways
Paskeh, M. D. A., Mirzaei, S., Ashrafizadeh, M., Zarrabi, A., & Sethi, G. (2021) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s336858 · Cited by 140
Tumor Dormancy and Cancer Stem Cells: Two Sides of the Same Coin?
Kleffel, S., & Schatton, T. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-1445-2_8 · Cited by 140
Mechanisms of syngeneic tumor rejection. Susceptibility of host-selected progressor variants to various immunological effector cells.
Urban, J. L., Burton, R. C., Holland, J. M., Kripke, M. L., & Schreiber, H. W. (1982) · The Journal of Experimental Medicine · doi:10.1084/jem.155.2.557 · Cited by 135
Maftools: Efficient analysis, visualization and summarization of MAF files from large-scale cohort based cancer studiesPreprint
Mayakonda, A., & Koeffler, H. P. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/052662 · Cited by 136
Cancer stem cells: Back to Darwin?
Greaves, M. F. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.03.002 · Cited by 137
How Cancer Shapes Evolution and How Evolution Shapes Cancer
Casás‐Selves, M., & DeGregori, J. V. (2011) · Evolution Education and Outreach · doi:10.1007/s12052-011-0373-y · Cited by 134
Integrative inference of subclonal tumour evolution from single-cell and bulk sequencing data
Malikić, S., Jahn, K., Kuipers, J., Şahinalp, S. C., & Beerenwinkel, N. (2019) · Nature Communications · doi:10.1038/s41467-019-10737-5 · Cited by 137
Formation of the tetraploid intermediate is associated with the development of cells with more than four centrioles in the elastase-simian virus 40 tumor antigen transgenic mouse model of pancreatic cancer.
Levine, D. S., Sanchez, C. A., Rabinovitch, P. S., & Reid, B. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6427 · Cited by 134
Single-cell analysis of somatic mutations in human bronchial epithelial cells in relation to aging and smoking
Huang, Z., Sun, S., Lee, M., Maslov, A. Y., Shi, M., Waldman, S., Marsh, A., Siddiqui, T., Dong, X., Peter, Y., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01035-w · Cited by 125
Sunitinib rechallenge in metastatic renal cell carcinoma patients
Zama, I. N., Hutson, T. E., Elson, P. J., Cleary, J. M., Choueiri, T. K., Heng, D. Y. C., Ramaiya, N. H., Michaelson, M. D., Garcia, J. A., Knox, J. J., et al. (2010) · Cancer · doi:10.1002/cncr.25583 · Cited by 132
Nanomedicine-mediated cancer stem cell therapy
Shen, S., Xia, J., & Wang, J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.09.037 · Cited by 132
Cancer-mutation network and the number and specificity of driver mutations
Iranzo, J., Martincorena, I., & Koonin, E. V. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1803155115 · Cited by 136
Cancer cell cycle heterogeneity as a critical determinant of therapeutic resistance
Maleki, E. H., Bahrami, A. R., & Matin, M. M. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2022.11.025 · Cited by 138
Cancer initiation and progression: Involvement of stem cells and the microenvironment
Tysnes, B. B., & BJERKVIG, R. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.01.001 · Cited by 138
Clonal Architecture of Secondary Acute Myeloid Leukemia Defined by Single-Cell Sequencing
Hughes, A. E. O., Magrini, V. J., Demeter, R., Miller, C. A., Fulton, R. S., Fulton, L., Eades, W. C., Elliott, K., Heath, S. E., Westervelt, P., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004462 · Cited by 131
microRNAs as cancer therapeutics: A step closer to clinical application
Ivković, T. C., Voss, G., Cornellà, H., & Ceder, Y. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.04.007 · Cited by 134
Heterogeneity in the Distribution ofRET/PTCRearrangements within Individual Post-Chernobyl Papillary Thyroid Carcinomas
Unger, K., Zitzelsberger, H. F., Salvatore, G., Santoro, M. M., Ti, B., Braselmann, H., Kastner, P., Zurnadzhy, L., Tronko, N., Hutzler, P., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031870 · Cited by 132
Amplified expression of the HER2/ERBB2 oncogene induces resistance to tumor necrosis factor alpha in NIH 3T3 cells.
Hudziak, R. M., Lewis, G. D., Shalaby, M. R., Eessalu, T. E., Aggarwal, B. B., Ullrich, A., & Shepard, H. M. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5102 · Cited by 132
Assessment of clonality in human tumors: a review.
Wainscoat, J. S., & Fey, M. F. (1990) · PubMed · Cited by 132
Conditional Selection of Genomic Alterations Dictates Cancer Evolution and Oncogenic Dependencies
Mina, M., Raynaud, F., Tavernari, D., Battistello, E., Sungalee, S., Saghafinia, S., Laessle, T., Sanchez-Vega, F., Schultz, N., Oricchio, E., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.06.010 · Cited by 129
DNA replication timing and selection shape the landscape of nucleotide variation in cancer genomes
Woo, Y., & Li, W. (2012) · Nature Communications · doi:10.1038/ncomms1982 · Cited by 133
Evolutionary game theory: cells as players
Hummert, S., Bohl, K., Basanta, D., Deutsch, A., Werner, S., Theißen, G., Schroeter, A., & Schuster, S. (2014) · Molecular BioSystems · doi:10.1039/c3mb70602h · Cited by 137
Mouse models in oncogenesis and cancer therapy
Céspedes, M. V., Casanova, I., Parreño, M., & Mangues, R. (2006) · Clinical & Translational Oncology · doi:10.1007/s12094-006-0177-7 · Cited by 130
Silencing the MET oncogene leads to regression of experimental tumors and metastases
Corso, S., Migliore, C., Ghiso, E., Rosa, G. D., Comoglio, P. M., & Giordano, S. (2007) · Oncogene · doi:10.1038/sj.onc.1210697 · Cited by 129
Variable Levels of Chromosomal Instability and Mitotic Spindle Checkpoint Defects in Breast Cancer
Yoon, D.-S., Wersto, R. P., Zhou, W., Chrest, F. J., Garrett, E. S., Kwon, T. K., & Gabrielson, E. W. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64194-6 · Cited by 131
Clonal Selection of Metastasis within the Life History of a Tumor
Talmadge, J. E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2496 · Cited by 131
Review: Precision medicine and driver mutations: Computational methods, functional assays and conformational principles for interpreting cancer drivers
Nussinov, R., Jang, H., Tsai, C., & Cheng, F. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006658 · Cited by 134
Deciphering Tumour Heterogeneity: From Tissue to Liquid Biopsy
Gilson, P., Merlin, J., & Harlé, A. (2022) · Cancers · doi:10.3390/cancers14061384 · Cited by 138
Periodontitis and risk of cancer: Mechanistic evidence
Baima, G., Minoli, M., Michaud, D. S., Aimetti, M., Sanz, M., Loos, B. G., & Romandini, M. (2023) · Periodontology 2000 · doi:10.1111/prd.12540 · Cited by 131
Mechanism of up-regulated gap junctional intercellular communication during chemoprevention and chemotherapy of cancer
Trosko, J. E., & Chang, C. (2001) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(01)00181-6 · Cited by 131
Hereditary breast cancer
Robson, M. E., Boyd, J. A., Borgen, P. I., & Cody, H. S. (2001) · Current Problems in Surgery · doi:10.1016/s0011-3840(01)70035-4 · Cited by 133
Interpreting epithelial cancer biology in the context of stem cells: Tumor properties and therapeutic implications
Miller, S. J., Lavker, R. M., & Sun, T. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.07.003 · Cited by 129
Simultaneous DNA and RNA Mapping of Somatic Mitochondrial Mutations across Diverse Human Cancers
Stewart, J. B., Alaei-Mahabadi, B., Sabarinathan, R., Samuelsson, T., Gorodkin, J., Gustafsson, C. M., & Larsson, E. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005333 · Cited by 126
Complexity of cancer stem cells
Sugihara, E., & Saya, H. (2013) · International Journal of Cancer · doi:10.1002/ijc.27961 · Cited by 132
Effect Sizes of Somatic Mutations in Cancer
Cannataro, V. L., Gaffney, S. G., & Townsend, J. P. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy168 · Cited by 128
Field Cancerization in the Intestinal Epithelium of Patients With Crohn's Ileocolitis
Galandiuk, S., Rodriguez‐Justo, M., Jeffery, R. E., Nicholson, A. M., Cheng, Y., Oukrif, D., Elia, G., Leedham, S. J., McDonald, S. A. C., Wright, N. A., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.12.004 · Cited by 128
Lack of intratumoral heterogeneity in DNA ploidy pattern of hepatocellular carcinoma.
Nagasue, N., Kohno, H., Hayashi, T., Yamanoi, A., Uchida, M., Takemoto, Y., Makino, Y., Ono, T., Hayashi, J., & Nakamura, T. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90150-b · Cited by 134
Cancer stem cell: Fundamental experimental pathological concepts and updates
Islam, F., Qiao, B., Smith, R. A., Gopalan, V., & Lam, A. K.-Y. (2015) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2015.02.002 · Cited by 131
Functional Interaction between Responses to Lactic Acidosis and Hypoxia Regulates Genomic Transcriptional Outputs
Tang, X., Lucas, J. E., Chen, J. L.-Y., LaMonte, G., Wu, J., Wang, M. C., Koumenis, C., & Chi, J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2076 · Cited by 130
Chromothripsis in cancer cells: An update
Rode, A., Maaß, K. K., Willmund, K. V., Lichter, P., & Ernst, A. (2015) · International Journal of Cancer · doi:10.1002/ijc.29888 · Cited by 125
Clonal evolution in leukemia
Ferrando, A. A., & López-Otín, C. (2017) · Nature Medicine · doi:10.1038/nm.4410 · Cited by 132
Mechanisms of chromosome instability in cancers
Jefford, C. E., & Irminger‐Finger, I. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.02.005 · Cited by 129
Evaluation of the Clonal Relationship between Primary and Metastatic Renal Cell Carcinoma by Comparative Genomic Hybridization
Bissig, H., Richter, J., Desper, R., Meier, V. S., Schraml, P., Schäffer, A. A., Sauter, G., Mihatsch, M. J., & Moch, H. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65120-6 · Cited by 123
Evolved Tumor Suppression: Why Are We So Good at Not Getting Cancer?
DeGregori, J. V. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0342 · Cited by 127
Indomethacin therapy abrogates the prostaglandin-mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastasis
Lala, P. K., Parhar, R. S., & Singh, P. (1986) · Cellular Immunology · doi:10.1016/0008-8749(86)90220-0 · Cited by 127
c-K-ras and p53 mutations occur very early in adenocarcinoma of the lung
Li, Z. H. (1995) · Lung Cancer · doi:10.1016/0169-5002(95)96453-3 · Cited by 127
Clinical Implications of Tumor-Cell Heterogeneity
Epstein, F. H., & Schnipper, L. E. (1986) · New England Journal of Medicine · doi:10.1056/nejm198605293142206 · Cited by 128
Optimizing sparse sequencing of single cells for highly multiplex copy number profilingPreprint
Baslan, T., Kendall, J., Ward, B., Cox, H., Leotta, A., Rodgers, L., Riggs, M. G., D'Italia, S., Sun, G., Mao, Y., et al. (2015) · Genome Research · doi:10.1101/gr.188060.114 · Cited by 123
TrAp: a tree approach for fingerprinting subclonal tumor composition
Strino, F., Parisi, F., Micsinai, M., & Kluger, Y. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt641 · Cited by 126
Receptor Tyrosine Kinase Genes Amplified in Glioblastoma Exhibit a Mutual Exclusivity in Variable Proportions Reflective of Individual Tumor Heterogeneity
Little, S. E., Popov, S., Jury, A., Bax, D. A., Doey, L. J., Al‐Sarraj, S., Jürgensmeier, J. M., & Jones, C. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4069 · Cited by 123
The emerging links between chromosomal instability (CIN), metastasis, inflammation and tumour immunity
Tijhuis, A. E., Johnson, S. C., & McClelland, S. E. (2019) · Molecular Cytogenetics · doi:10.1186/s13039-019-0429-1 · Cited by 131
Biomarkers in Barrett's esophagus
Reid, B. J., Blount, P. L., & Rabinovitch, P. S. (2003) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/s1052-5157(03)00006-0 · Cited by 126
Tumour Cell Heterogeneity
Gay, L. J., Baker, A., & Graham, T. A. (2016) · F1000Research · doi:10.12688/f1000research.7210.1 · Cited by 129
An integrative analysis of the age-associated multi-omic landscape across cancers
Chatsirisupachai, K., Lesluyes, T., Paraoan, L., Loo, P. V., & de Magalhães, J. P. (2021) · Nature Communications · doi:10.1038/s41467-021-22560-y · Cited by 128
Radiation-induced genomic instability: a paradigm-breaking phenomenon and its relevance to environmentally induced cancer
Baverstock, K. (2000) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(00)00100-7 · Cited by 125
Game-theory models of interactions between tumour cells
Tomlinson, I. P. M. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00170-6 · Cited by 125
Clonal divergence and genetic heterogeneity in clear cell renal cell carcinomas with sarcomatoid transformation
Jones, T. D., Eble, J. N., Wang, M., MacLennan, G. T., Jain, S. K., & Liang Cheng, C. (2005) · Cancer · doi:10.1002/cncr.21288 · Cited by 125
Possible epigenetic mechanisms of tumor progression: Induction of high-frequency heritable but phenotypically unstable changes in the tumorigenic and metastatic properties of tumor cell populations by 5-azacytidine treatment
Kerbel, R. S., Frost, P., Liteplo, R. G., Carlow, D. A., & Elliott, B. E. (1984) · Journal of Cellular Physiology · doi:10.1002/jcp.1041210411 · Cited by 125
Chromosomal banding patterns in human large bowel cancer
Reichmann, A., Martin, P. K., & Levin, B. (1981) · International Journal of Cancer · doi:10.1002/ijc.2910280407 · Cited by 125
Image-guided genomics of phenotypically heterogeneous populations reveals vascular signalling during symbiotic collective cancer invasion
Konen, J. M., Summerbell, E. R., Dwivedi, B., Galior, K. D., Hou, Y., Rusnak, L., Chen, A., Saltz, J. H., Zhou, W., Boise, L., et al. (2017) · Nature Communications · doi:10.1038/ncomms15078 · Cited by 124
Multiple myeloma clonal evolution in homogeneously treated patients
Corre, J., Cleynen, A., Robiou-du-Pont, S., Buisson, L., Bolli, N., Attal, M., Munshi, N. C., & Avet‐Loiseau, H. (2018) · Leukemia · doi:10.1038/s41375-018-0153-6 · Cited by 128
Clonal evolution of acute myeloid leukemia from diagnosis to relapse
Vosberg, S., & Greif, P. A. (2019) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22806 · Cited by 135
Cooperation and conflict in the evolution of individuality. II. Conflict mediation
Michod, R. E. (1996) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1996.0121 · Cited by 122
Activation of MYC in a masked t(8;17) translocation results in an aggressive B-cell leukemia.
Gauwerky, C. E., Huebner, K., Isobe, M., Nowell, P. C., & Croce, C. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.22.8867 · Cited by 125
Self-citation
Cell adhesion receptor expression during melanoma progression and metastasis
Hart, I. R., Birch, M. L., & Marshall, J. F. (1991) · Cancer and Metastasis Reviews · doi:10.1007/bf00049409 · Cited by 124
Translational potential of cancer stem cells: A review of the detection of cancer stem cells and their roles in cancer recurrence and cancer treatment
Islam, F., Gopalan, V., Smith, R. A., & Lam, A. K.-Y. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.04.018 · Cited by 132
Integration of phytochemicals and phytotherapy into cancer precision medicine
Efferth, T., Saeed, M. E. M., Mirghani, E., Alim, A., Yassin, Z., Saeed, E. M., Khalid, H. E., & Daak, S. (2017) · Oncotarget · doi:10.18632/oncotarget.17466 · Cited by 125
Genetic inactivation of AKT1 , AKT2 , and PDPK1 in human colorectal cancer cells clarifies their roles in tumor growth regulation
Ericson, K., Gan, C. M., Cheong, I., Rago, C., Samuels, Y., Velculescu, V. E., Kinzler, K. W., Huso, D. L., Vogelstein, B., & Papadopoulos, N. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914018107 · Cited by 122
Problems of somatic mutation and cancer
Frank, S. A., & Nowak, M. A. (2004) · BioEssays · doi:10.1002/bies.20000 · Cited by 129
Pretumor Progression
Calabrese, P. P., Tavaré, S., & Shibata, D. K. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63220-8 · Cited by 121
miRNA Biomarkers in Breast Cancer Detection and Management
Fu, S. W., Chen, L., & Man, Y. (2011) · Journal of Cancer · doi:10.7150/jca.2.116 · Cited by 125

Authors: Nowell, P. C.
Affiliations: School of Medicine, University of Pennsylvania, Philadelphia 19174.
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 1976-10
Volume: 194
Issue: 4260
Pages: 23-28
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.959840
OpenAlex: W1967304777
Cited by: 6,471
References: 52
Citations by year: 2026: 117 · 2025: 163 · 2024: 183 · 2023: 201 · 2022: 209 · 2021: 282 · 2020: 287 · 2019: 259 · 2018: 304 · 2017: 332 · 2016: 263 · 2015: 261 · 2014: 241 · 2013: 233 · 2012: 200
FWCI: 16.73
Type: journal article
Language: en
Open access: closed
Locations: Science (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
Keywords: clonal evolution, tumor progression, karyotypic heterogeneity, tumor cell populations, treatment resistance, carcinogen exposure, precision oncology
MeSH terms: Carcinogens, Chromosomes, Clone Cells, Karyotyping, Models, Biological, Mutation, Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Clonal Evolution of Tumor Cell Populations: Acquired genetic lability permits stepwise selection of variant sublines and underlies tumor progression.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks